IDI-ARABA, LAGOS STATE— In a significant increase to Nigeria’s tertiary health care capability, the Shell Nigeria Expedition and Production Business (SNEPCo) and the Nigerian National Petroleum Business (NNPC) Limited Joint Endeavor have contributed a suite of innovative lung diagnostic equipment to the Lagos University Mentor Medical Facility (LUTH).
The donation, which includes an Endobronchial Ultrasound (EBUS) system and a Body Plethysmograph, positions LUTH as a premier center for high-precision breathing care in West Africa.
The official handover ceremony, held at the LUTH Idi-Araba campus, was described by health stakeholders as a landmark event that bridges the space between traditional medical assessment and technology-enabled evidence-based medicine.
Precision Diagnostics for Lung Cancer
The EBUS system is a game-changer for oncology in Nigeria. Generally, lung biopsies were often invasive or did not have the precision required for accurate staging.
The new EBUS technology allows clinicians to perform real-time assisted biopsies of the lungs and lymph nodes, which is vital for figuring out the specific treatment course for lung cancer clients.
Clinical Abilities of the New Systems:
-
EBUS System: Facilitates minimally intrusive, real-time imaging of the airways and surrounding structures, permitting precise staging of thoracic malignancies.
-
Body Plethysmograph: Often described as a “body box,” this devices determines functional residual capacity and overall lung capacity, supplying the most accurate diagnosis for asthma, COPD, and restrictive lung diseases.
Read likewise: UNILORIN and NNPCL form strategic committee for West Africa’s very first engineering centre of excellence.
A Shift Towards Evidence-Based Care
Speaking at the occasion, SNEPCo Handling Director Ronald Adams, represented by General Supervisor of Communications, Abubakar Ahmed, stressed that the intervention represents an essential shift in Nigeria’s medical landscape.
“It is a shift from constrained diagnostics to evidence-based, technology-enabled respiratory care,” Adams stated.
He noted that the devices empowers clinicians to practice at the full height of their training, guaranteeing that patients no longer require to travel abroad for specialised pulmonary tests.
The Chief Upstream Financial Investment Officer of NNPC Upstream Financial Investment Management Provider (NUIMS), Olanrewaju Igandan, reaffirmed the JV’s commitment to social investment.
Represented by Edith Bunmi-Lawson, Igandan noted that nationwide advancement is insufficient without resilient healthcare organizations.
“This initiative shows our belief that sustainable nationwide development exceeds energy production. It is about improving lives and investing in systems that withstand,” he remarked.
Landmark Impact on Public Health
The Chief Medical Director of LUTH, Professor Wasiu Lanre Adeyemo, represented by the Deputy Chairman of the Medical Advisory Committee, Prof. Babawale, thanked the donors for offering access to specialised care within the public sector.
He noted that such advanced devices is seldom available in public healthcare facilities, and its arrival will substantially enhance the outcomes for patients with complex breathing disorders across Nigeria.
As LUTH integrates these systems into its day-to-day clinical operations, the healthcare facility anticipates a surge in recommendations from across the country, reinforcing its position as a centre of quality in medical research and training.